Testing effectiveness (Phase 2)Study completedNCT00958100
What this trial is testing
Raltegravir Switch for Toxicity or Adverse Events
Who this might be right for
HIV/AIDSAntiretroviral TherapyHIV Infections
Catholic University of the Sacred Heart 40